Literature DB >> 3707633

D-penicillamine-induced polymyositis in patients with rheumatoid arthritis.

K Takahashi, T Ogita, H Okudaira, S Yoshinoya, H Yoshizawa, T Miyamoto.   

Abstract

Among 329 patients with rheumatoid arthritis treated with D-penicillamine (DP), we found 4 cases of polymyositis. This incidence was significantly higher than the expected coincidence of rheumatoid arthritis and polymyositis/dermatomyositis or than the presumed frequency of this complication among patients treated with DP. In the present report, we summarize and discuss the clinical findings in DP-induced polymyositis/dermatomyositis in our patients and others described in the literature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707633     DOI: 10.1002/art.1780290416

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Beyond the joints: neurological involvement in rheumatoid arthritis.

Authors:  Cesar Ramos-Remus; Sergio Duran-Barragan; Jose Dionisio Castillo-Ortiz
Journal:  Clin Rheumatol       Date:  2011-09-20       Impact factor: 2.980

Review 2.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 3.  The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.

Authors:  L E Hart; P Tugwell
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

Review 4.  Juvenile rheumatoid arthritis: therapeutic perspectives.

Authors:  Ian C Chikanza
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Secondary Causes of Myositis.

Authors:  Sarah H Berth; Thomas E Lloyd
Journal:  Curr Treat Options Neurol       Date:  2020-10-06       Impact factor: 3.598

6.  D-penicillamine induced polymyositis causing complete heart block.

Authors:  G D Wright; C Wilson; A L Bell
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

7.  Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.

Authors:  J M Schröder; M Bertram; R Schnabel; U Pfaff
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Polymyositis complicating D-penicillamine treatment.

Authors:  A O Aydintug; R Cervera; D D'Cruz; G Ramírez; R A Asherson; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

9.  A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine.

Authors:  J H Ahn; T H Kim; K R Peck; Y W Song
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.